Lili Wu

机构：Zhejiang Wanli University, Nanjing University of Finance and Economics, Tianjin Normal University, Chinese Academy of Sciences, Animal Husbandry & Veterinary, Northeast Institute of Geography and Agroecology, Panzhihua University, Institute of Microbiology, New Hope Liuhe (China), University of Chinese Academy of Sciences · ORCID：0000-0002-6749-1727

发表论文 51 篇 · 总被引 5037 次 · h-index 19

代表论文

• An updated atlas of antibody evasion by SARS-CoV-2 Omicron sub-variants including BQ.1.1 and XBB (2023 · Cell Reports Medicine · 被引 94)
• Two pan-SARS-CoV-2 nanobodies and their multivalent derivatives effectively prevent Omicron infections in mice (2023 · Cell Reports Medicine · 被引 49)
• Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infections (2024 · Nature Communications · 被引 45)
• Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2 (2023 · Proceedings of the National Academy of Sciences · 被引 36)
• A pan-coronavirus peptide inhibitor prevents SARS-CoV-2 infection in mice by intranasal delivery (2023 · Science China Life Sciences · 被引 26)
• Host range and structural analysis of bat‐origin RshSTT182/200 coronavirus binding to human ACE2 and its animal orthologs (2022 · The EMBO Journal · 被引 19)